1 September 2020 - House Oversight and Reform Committee Democrats are planning to subpoena drug manufacturer AbbVie for documents related to two of its most popular products as part of the panel's investigation into rising drug prices.

"After more than 18 months, AbbVie has demonstrated its unwillingness to comply voluntarily with the Committee’s investigation,” committee Chairwoman Carolyn Maloney wrote in a memo announcing the subpoena.

"Although most of the drug companies we are examining have cooperated with the committee's investigation, AbbVie's noncompliance stands out as particularly egregious, which is why I am issuing this subpoena," Maloney said.

Read The Hill article